Quantum-Si Inc. held its Investor & Analyst Day in New York City, where the company's management team provided updates on the development of the Proteus™ platform. Highlights included recent progress in platform development, a long-term technology roadmap aimed at achieving billions of reads, advancements toward coverage of all 20 amino acids, and new methods for detecting post-translational modifications. The company also shared data from over 50 sequencing runs on Proteus prototype systems, noting that performance already meets or exceeds that of the current Platinum® Pro system. Attendees were able to participate virtually by registering for the event.